Press Releases

Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial

Elucid’s Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time. The dashboard is automatically created by the dispensing of the pill/tablet through the intelligent Pill Connect cap which fits on any standard pill bottle. The patient receives a reminder on their phone when the pill or pills should be taken. The patient then touches the dispense button on the screen and the pill is ejected from the bottle and a signal is sent, via the phone, that the pill has been dispensed.

Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases

Quantabio's UltraPlex 1-Step ToughMix was recognized as part of the new EUA for the CDC) Influenza SARS-CoV-2 (Flu SC2 Multiplex Assay.

VERICHEM LABORATORIES OFFERS FREE, CLIA COMPLIANT, WEB-BASED CALIBRATION VERIFICATION DATA REDUCTION SERVICES

VERICHEM LABORATORIES now offers all its customers free access to the company’s online, web-based, data reduction services that supports all necessary statistics required within the clinical laboratory to satisfy current CLIA and CAP requirements for the calibration verification of clinical assays.

Creative BioMart Updated Its Bacterial Expression Systems for Protein Expression Service

Creative Biostructure Released Cryo-EM for Gene Therapy

Profacgen Updated Its CLIP-Seq Service for RNA-Protein Interaction Study

Matexcel Enlarged Its Chitosan Products Offerings

Lifeasible Supports a Comprehensive Range of Environmental Tests

Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants

The global cases of COVID-19 are expected to soar unceasingly, and to facilitate related research worldwide, Creative Diagnostics integrates recombinant SARS-CoV-2 RBD mutants to its SARS-CoV-2 products and services.

CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations

As a top-class institution as well as experienced supplier in drug delivery, CD Bioparticles now launches cover-all PEG conjugations to global clients.

Tasso Secures $17 Million Series A Financing to Scale Production of At-Home Blood Collection Systems and Capitalize on Growing Demand for Remote Diagnostic Testing

Tasso Inc. completes an oversubscribed $17 million Series A financing round to scale production of at-home blood collection systems

Prospective Study Finds Potential Utility of MeMed's Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

Rapid and Continuous Measurement of the Host-Immune Response with MeMed Key™ May Help Clinicians Predict COVID19 Disease Severity, Monitor Inflammatory Status and Guide Treatment Decisions

ndd’s new inline filters offer additional protection against COVID-19 during lung function tests

Andover, MA – 21 July 2020. ndd Medical Technologies (ndd), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has introduced new single patient-use, inline filters for its lung function testing devices, in response to the global COVID-19 pandemic. Ensuring an added level of safety, the new filters can be used with ndd’s revolutionary, and highly portable EasyOne® spirometry range, including the EasyOne Air, EasyOne Pro, and EasyOne Pro LAB. EasyOne spirometers are popular among pulmonologists and medical researchers as they are of the most sensitive devices available, delivering reliable, real-time lung function results and diagnosis of chronic lung diseases, even at the point of care.

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd (SB3000 Ltd), a pioneer in green, continuous manufacturing of pharmaceutical products.

BioIVT Supports COVID-19 Drug, Diagnostic and Vaccine Researchers by Expanding its Inventory of Patient Plasma, Serum and Saliva Specimens

Specimens can be used to validate SARS-CoV-2 in-vitro diagnostics, develop new drugs and vaccines, and investigate the impact of co-morbidities and social demographics on disease progression

Wearable, Wireless Biometric Sensor Devices from Shimmer Provide Much-Needed Patient Data in Battle Against COVID-19

Bio-Gate signs cooperation agreement with Aesculap AG for coating revision implants

Accumen Launches National Health System Crisis Readiness Survey to Provide Benchmarks and Insights to U.S. Hospitals

Survey will gather data from hospital laboratory, blood management, imaging, and data departments across the nation 

CD Genomics Upgrades Highly Accurate Single-Cell Sequencing Services for Researchers

Creative Enzymes Launches Enzymes for Coronavirus Nucleic Acid Test to Help the Detection of COVID-19